Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India · Delayed Price · Currency is INR | Market Cap | 133.58B -3.0% |
| Revenue (ttm) | 89.83B +27.3% |
| Net Income | 4.33B +47.5% |
| EPS | 2.33 +43.4% |
| Shares Out | 1.85B |
| PE Ratio | 30.99 |
| Forward PE | 25.68 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 141,081 |
| Open | 72.78 |
| Previous Close | 72.78 |
| Day's Range | 71.02 - 73.20 |
| 52-Week Range | 67.50 - 91.40 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 99.09 (+37.21%) |
| Earnings Date | Nov 4, 2026 |
About NSE:NIVABUPA
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness, disease-specific, hospital cash, and maternity insurance; travel insurance plans, including international and studying abroad insurance; and corporate insurance plans comprising group and start up health, group personal accident, and OPD coverage, as well as group health insurance claim process. The company was formerly known as Max Bupa ... [Read more]
Financial Performance
In fiscal year 2026, NSE:NIVABUPA's revenue was 84.43 billion, an increase of 33.38% compared to the previous year's 63.30 billion. Earnings were 3.66 billion, an increase of 80.45%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for NIVABUPA stock is "Buy." The 12-month stock price target is ₹99.09, which is an increase of 37.21% from the latest price.
News
Niva Bupa Health Insurance Company Transcript: Investor update
Revised summary: Management expects IRDAI's proposed reforms to drive volume growth, customer benefits, and better economics, especially in retail health. Expense ratios should decline, boosting short-term profitability, with long-term neutrality as benefits pass to customers. Channel strategies and digital transformation will enhance efficiency.
Niva Bupa Health Insurance Company Transcript: Q1 26/27
Q1 saw robust growth, with retail health outpacing the industry and profit after tax rising to INR 137.8 crore. Key ratios improved, expense management strengthened, and digital initiatives advanced. Guidance remains for above-market retail growth and stable margins.
Niva Bupa Health Insurance Company Quarterly report: Q1 2027
Niva Bupa Health Insurance Company has published its Q1 2027 quarterly earnings report on July 30, 2026.
Niva Bupa Health Insurance Company Slides: Q1 2027
Niva Bupa Health Insurance Company has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on July 30, 2026.
Niva Bupa Health Insurance Company Transcript: Q4 25/26
GWP grew 27.4% to INR 9,433 crore with 35% retail growth and profit after tax up 80% year-over-year. Combined ratio improved to 101.4%, and the company targets 25% annual growth, leveraging digital and distribution expansion. Retail health loss ratio improved, and industry initiatives are driving transparency.
Niva Bupa Health Insurance Company Quarterly report: Q4 2026
Niva Bupa Health Insurance Company has published its Q4 2026 quarterly earnings report on May 8, 2026.
Niva Bupa Health Insurance Company Slides: Q4 2026
Niva Bupa Health Insurance Company has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 8, 2026.
Niva Bupa Health Insurance Company Annual report: Q4 2026
Niva Bupa Health Insurance Company has published its Q4 2026 annual report on May 8, 2026.
Niva Bupa Health Insurance Company Transcript: Q3 25/26
Strong nine-month growth with PAT up 74% year-over-year and market share gains, supported by robust channel performance and digital initiatives. Industry-wide standardization, GST tailwinds, and regulatory clarity are expected to sustain growth and improve cost control.
Niva Bupa Health Insurance Company Quarterly report: Q3 2026
Niva Bupa Health Insurance Company has published its Q3 2026 quarterly earnings report on January 29, 2026.
Niva Bupa Health Insurance Company Slides: Q3 2026
Niva Bupa Health Insurance Company has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 29, 2026.
Niva Bupa Health Insurance Company Transcript: Q2 25/26
H1 FY '26 saw 23% overall and 28% retail GWP growth, with PAT more than doubling year-over-year. GST reduction to 0% spurred over 50% retail growth in October, while combined and expense ratios improved. Group loss ratio rose due to mix, but retail remained stable.
Niva Bupa Health Insurance Company Quarterly report: Q2 2026
Niva Bupa Health Insurance Company has published its Q2 2026 quarterly earnings report on November 3, 2025.
Niva Bupa Health Insurance Company Slides: Q2 2026
Niva Bupa Health Insurance Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 3, 2025.